Sodium-Glucose Cotransporter 2 Inhibitors: An Overview Sodium-Glucose Cotransporter 2 Inhibitors: An Overview

SGLT2 inhibitors are promising new agents for the treatment of type 2 diabetes, but there are risks to be considered. Which patients would most benefit?U.S. Pharmacist

Source: Medscape Today Headlines - March 21, 2018 Category: Consumer Health News Tags: Pharmacist Journal Article Source Type: news